Quantitative neuroimaging in mucolipidosis type IV.

Area of Science:

• Neuroscience
• Genetics
• Medical Imaging

Background:

• Mucolipidosis type IV (MLIV) is an autosomal recessive disorder linked to MCOLN1 gene mutations.
• MLIV patients exhibit neurodevelopmental abnormalities and progressive retinal dystrophy.
• The MCOLN1 gene encodes the mucolipin-1 (TRPML1) channel protein, crucial for endosomal/lysosomal function.

Purpose of the Study:

• To investigate a potential slow cerebral neurodegenerative process in MLIV patients.
• To assess neurodevelopmental status and brain structural changes over time.
• To evaluate diffusion-weighted imaging as a biomarker for MLIV.

Main Methods:

• Prospective natural history study involving 5 MLIV patients.
• Annual neurodevelopmental assessments and MRI scans (regional volumes, white matter integrity).
• Analysis of diffusion metrics: Mean Diffusivity (MD) and Fractional Anisotropy (FA).

Main Results:

• MLIV patients remained neurologically stable over 3 years.
• Trends observed: increased gray matter and ventricular volumes, decreased white matter and cerebellar volumes.
• Elevated MD and reduced FA in all brain regions; correlations found between motor scores and FA/MD in the corticospinal tract.

Conclusions:

• Mucolipin-1 deficiency impacts the entire brain, suggesting a selective regional neurodegenerative process in MLIV.
• Diffusion-weighted imaging (DWI) shows promise as a biomarker for monitoring MLIV progression.
• Findings may inform the design of future clinical trials for MLIV.